Objectives: Controversy exists as to whether uterine leiomyosarcomas (ULMS) and extrauterine leiomyosarcomas (ELMS) represent distinct pathological and molecular entities. We aim to evaluate molecular, genomic, and protein expression patterns in a large cohort of leiomyosarcomas (LMS) in hopes of identifying novel treatment strategies.
Publications
Uterine leiomyosarcomas exhibit distinct drug resistance molecular profiles compared to extrauterine leiomyosarcomas – A comprehensive analysis of 1023 leiomyosarcomas
– Caris Life Sciences
Download Publication